1. A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease
   Wei-Fan Hsu et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages
   Cong-hui Li et al, 2017, European Journal of Pharmacology CrossRef
3. Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cells
   Wen-Chung Huang et al, 2018, Saudi Pharmaceutical Journal CrossRef
4. Natural product puerarin activates Akt and ameliorates glucose and lipid metabolism dysfunction in hepatic cells
   Yunbing Shen et al, 2019, Journal of Functional Foods CrossRef
5. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease
   null Kong et al, 2019, IJMS CrossRef
6. Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells
   Jing Zhang et al, 2019, European Journal of Pharmacology CrossRef
7. Regulation of AMP-activated protein kinase by natural and synthetic activators
   David Grahame Hardie, 2016, Acta Pharmaceutica Sinica B CrossRef
8. Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway
   Lina Gu et al, 2016, Toxicology and Applied Pharmacology CrossRef
9. The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
   Sha Li et al, 2020, Front. Pharmacol. CrossRef
10. Puerarin protects endothelial progenitor cells from damage of angiotensin II via activation of ERK1/2‑Nrf2 signaling pathway
    Chen Fu et al, 2017, Mol Med Report CrossRef
11. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway
    Jiaxin Zhang et al, 2020, Journal of Immunology Research CrossRef
12. Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
    Siting Gao et al, 2020, Chin Med CrossRef
13. Alisol A Alleviates Arterial Plaque by Activating AMPK/SIRT1 Signaling Pathway in apoE-Deficient Mice
    Ke Wang et al, 2020, Front. Pharmacol. CrossRef
14. Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing
    Meng-juan Gong et al, 2021, Journal of Pharmaceutical and Biomedical Analysis CrossRef
15. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease
    Honglin Zhou et al, 2021, European Journal of Pharmacology CrossRef
16. Puerarin improves hepatic glucose and lipid homeostasis in vitro and in vivo by regulating the AMPK pathway
    Dong-Xue Xu et al, 2021, Food Funct. CrossRef
17. Use of Network Pharmacology to Explore the Mechanism of Gegen (Puerariae lobatae Radix) in the Treatment of Type 2 Diabetes Mellitus Associated with Hyperlipidemia.
    Guozhen Yuan et al, 2021, Evid Based Complement Alternat Med CrossRef
18. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
    Xianmin Dai et al, 2021, Chin Med CrossRef
19. Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
    Jiashu Pan et al, 2022, Biomedicine & Pharmacotherapy CrossRef
20. The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
    Gaoxuan Shao et al, 2022, Front. Pharmacol. CrossRef
21. Puerarin attenuates hepatic steatosis via G-protein-coupled estrogen receptor-mediated calcium and SIRT1 signaling pathways.
    Hye gwang Jeong, 0 CrossRef
22. Literature Review on the Use of Herbal Extracts in the Treatment of Non- Alcoholic Fatty Liver Disease
    Yutian Wang et al, 2022, EMIDDT CrossRef
23. A Review of the Effects of Puerarin on Glucose and Lipid Metabolism in Metabolic Syndrome: Mechanisms and Opportunities
    Xiaoxuan Jing et al, 2022, Foods CrossRef
24. The great potential of flavonoids as candidate drugs for NAFLD
    Liangge Li et al, 2023, Biomedicine & Pharmacotherapy CrossRef
25. Tartary Buckwheat Flavonoids Relieve Non-alcoholic Fatty Liver Disease by Inhibiting Lipid Accumulation, Inflammation, and Regulating Intestinal Flora
    Ping Xu et al, 2023, Rev. Bras. Farmacogn. CrossRef
26. Structural properties of Kudzu protein enzymatic hydrolysate and its repair effect on HepG2 cells damaged by H2O2 oxidation
    Huina Pang et al, 2023, Food Funct. CrossRef
27. Effects of Apple Polyphenols and Taurine on Growth Performance, Tissue Morphology, and Lipid and Glucose Metabolism in Rice Field Eel (Monopterus albus) Fed High Oxidized Fish Oil
    Shanshan Wu et al, 2023, Aquaculture Nutrition CrossRef
28. A Pueraria lobata root extract alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating the gut microbiota and associated metabolites
    Xin Tang et al, 2024, Food Bioscience CrossRef
29. Effects of Mactra chinenesis Peptides on Alcohol-Induced Acute Liver Injury and Intestinal Flora in Mice
    Dong Wu et al, 2024, Foods CrossRef
30. The food and medicinal homological resources benefiting patients with hyperlipidemia: categories, functional components, and mechanisms
    Xuting Hao et al, 2024 CrossRef
31. Pueraria lobata antioxidant extract ameliorates non-alcoholic fatty liver by altering hepatic fat accumulation and oxidative stress
    Hongying Dong et al, 2024, Journal of Ethnopharmacology CrossRef
32. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review
    Zhaolin Sun et al, 2024, Pharmacological Research - Modern Chinese Medicine CrossRef
33. Puerarin inhibits HDAC1-induced oxidative stress disorder by activating JNK pathway and alleviates acrolein-induced atherosclerosis
    YeTing Li et al, 2024, Clinics CrossRef
34. Food-Derived β-Carboline Alkaloids Ameliorate Lipid Droplet Accumulation in Human Hepatocytes
    Dya Fita Dibwe et al, 2022, Pharmaceuticals CrossRef
35. Celastrus orbiculatus Thunb. extracts and celastrol alleviate NAFLD by preserving mitochondrial function through activating the FGF21/AMPK/PGC-1α pathway
    Junli Xue et al, 2024, Front. Pharmacol. CrossRef
36. Targeting AMPK related signaling pathways: A feasible approach for natural herbal medicines to intervene non-alcoholic fatty liver disease
    Yongqing Cai et al, 2024, Journal of Pharmaceutical Analysis CrossRef
37. Protective effects of puerarin on metabolic diseases: Emphasis on the therapeutical effects and the underlying molecular mechanisms
    Qiang Wan et al, 2024, Biomedicine & Pharmacotherapy CrossRef